Roya Hooshmand-Rad

2.0k total citations
23 papers, 761 citations indexed

About

Roya Hooshmand-Rad is a scholar working on Epidemiology, Molecular Biology and Hepatology. According to data from OpenAlex, Roya Hooshmand-Rad has authored 23 papers receiving a total of 761 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 8 papers in Molecular Biology and 8 papers in Hepatology. Recurrent topics in Roya Hooshmand-Rad's work include Protein Kinase Regulation and GTPase Signaling (7 papers), Liver Diseases and Immunity (7 papers) and Liver Disease Diagnosis and Treatment (6 papers). Roya Hooshmand-Rad is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (7 papers), Liver Diseases and Immunity (7 papers) and Liver Disease Diagnosis and Treatment (6 papers). Roya Hooshmand-Rad collaborates with scholars based in Sweden, United States and United Kingdom. Roya Hooshmand-Rad's co-authors include Lena Claesson‐Welsh, James I. Ito, Sara M. Rankin, Carl‐Henrik Heldin, Koutaro Yokote, Enrique Rozengurt, Michael D. Waterfield, Anne J. Ridley, Claire M. Wells and Daniel Zicha and has published in prestigious journals such as Journal of Biological Chemistry, Gastroenterology and Nature Cell Biology.

In The Last Decade

Roya Hooshmand-Rad

23 papers receiving 746 citations

Peers

Roya Hooshmand-Rad
Cheng Fang Yu United States
V. Friand France
Angela Orecchia Italy
Nadezhda Tikhmyanova United States
Sandra van Wilpe Netherlands
Simona Vertuani Sweden
Marie-Pierre Podgorniak France
Honghong Sun China
Sylvain M. Le Gall France
Nuran Bektas Germany
Cheng Fang Yu United States
Roya Hooshmand-Rad
Citations per year, relative to Roya Hooshmand-Rad Roya Hooshmand-Rad (= 1×) peers Cheng Fang Yu

Countries citing papers authored by Roya Hooshmand-Rad

Since Specialization
Citations

This map shows the geographic impact of Roya Hooshmand-Rad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roya Hooshmand-Rad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roya Hooshmand-Rad more than expected).

Fields of papers citing papers by Roya Hooshmand-Rad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roya Hooshmand-Rad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roya Hooshmand-Rad. The network helps show where Roya Hooshmand-Rad may publish in the future.

Co-authorship network of co-authors of Roya Hooshmand-Rad

This figure shows the co-authorship network connecting the top 25 collaborators of Roya Hooshmand-Rad. A scholar is included among the top collaborators of Roya Hooshmand-Rad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roya Hooshmand-Rad. Roya Hooshmand-Rad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kremer, Andreas E., Ulrich Beuers, Tonya Marmon, et al.. (2016). Mitigation of Pruritus during Obeticholic Acid Treatment in Patients with Primary Biliary Cirrhosis: Strategies and Successes. Journal of Hepatology. 64(2). S636–S637. 2 indexed citations
2.
Karpen, Saul J., Lise Eliot, Michelle M. Merrigan, et al.. (2016). A Multicenter, Randomized, Open Label, Single- and Multiple-Dose, Dose Finding Study and Open-Label Extension to Assess the Effects of Obeticholic Acid in Pediatric Patients with Biliary Atresia. Journal of Hepatology. 64(2). S294–S294. 2 indexed citations
3.
Peters, Yonne, Roya Hooshmand-Rad, Richard Pencek, et al.. (2016). OC.12.8 LONG-TERM SAFETY OF OBETICHOLIC ACID IN PATIENTS WITH PRIMARY BILIARY CIRRHOSIS. Digestive and Liver Disease. 48. e117–e118. 1 indexed citations
4.
Beuers, Ulrich, et al.. (2016). 1111 Baseline Factors Predicting Obeticholic Acid Induced Pruritus in Patients with PBC. Gastroenterology. 150(4). S1058–S1058. 1 indexed citations
5.
Mayo, Marlyn J., Andreas E. Kremer, Ulrich Beuers, et al.. (2016). Sa1575 Mitigation of Pruritus During Obeticholic Acid Treatment in Patients With Primary Biliary Cirrhosis: Strategies and Successes. Gastroenterology. 150(4). S1072–S1072. 2 indexed citations
6.
7.
Kowdley, K.V., Gideon M. Hirschfield, Robert Chapman, et al.. (2014). P374 LONG-TERM TREATMENT OF PRIMARY BILIARY CIRRHOSIS WITH THE FXR AGONIST OBETICHOLIC ACID SHOWS DURABLE EFFICACY. Journal of Hepatology. 60(1). S192–S193. 3 indexed citations
8.
Mookerjee, Rajeshwar P., Matteo Rosselli, Giulia Pieri, et al.. (2014). O15 EFFECTS OF THE FXR AGONIST OBETICHOLIC ACID ON HEPATIC VENOUS PRESSURE GRADIENT (HVPG) IN ALCOHOLIC CIRRHOSIS: A PROOF OF CONCEPT PHASE 2A STUDY. Journal of Hepatology. 60(1). S7–S8. 18 indexed citations
9.
Nevens, Frederik, Pietro Andreoné, G. Mazzella, et al.. (2014). O168 THE FIRST PRIMARY BILIARY CIRRHOSIS (PBC) PHASE 3 TRIAL IN TWO DECADES – AN INTERNATIONAL STUDY OF THE FXR AGONIST OBETICHOLIC ACID IN PBC PATIENTS. Journal of Hepatology. 60(1). S525–S526. 24 indexed citations
10.
Luketic, Velimir A., Robert Chapman, Marlyn J. Mayo, et al.. (2014). P377 THE FXR AGONIST OBETICHOLIC ACID IMPROVES A TRANSPLANT-FREE SURVIVAL-PROVEN BIOCHEMICAL RESPONSE CRITERION IN PLACEBO CONTROLLED PRIMARY BILIARY CIRRHOSIS STUDIES. Journal of Hepatology. 60(1). S193–S194. 1 indexed citations
11.
Mookerjee, Rajeshwar P., et al.. (2012). Effect of the FXR Agonist Obeticholic acid on portal pressure in alcoholic cirrhosis: A proof of concept Phase 2a study. UCL Discovery (University College London). 1 indexed citations
12.
Ito, James I. & Roya Hooshmand-Rad. (2005). Treatment of Candida Infections with Amphotericin B Lipid Complex. Clinical Infectious Diseases. 40(Supplement_6). S384–S391. 40 indexed citations
13.
Ito, James I., Pranatharthi Chandrasekar, & Roya Hooshmand-Rad. (2005). Effectiveness of amphotericin B lipid complex (ABLC) treatment in allogeneic hematopoietic cell transplant (HCT) recipients with invasive aspergillosis (IA). Bone Marrow Transplantation. 36(10). 873–877. 19 indexed citations
14.
15.
Hooshmand-Rad, Roya, et al.. (2004). Use of amphotericin B lipid complex in elderly patients. Journal of Infection. 50(4). 277–287. 9 indexed citations
16.
Hooshmand-Rad, Roya, Lingge Lu, Carl‐Henrik Heldin, Lena Claesson‐Welsh, & Michael Welsh. (2000). Platelet-Derived Growth Factor-Mediated Signaling through the Shb Adaptor Protein: Effects on Cytoskeletal Organization. Experimental Cell Research. 257(2). 245–254. 20 indexed citations
17.
Asano, Tomoichiro, Akira Kanda, Hideki Katagiri, et al.. (2000). p110β Is Up-regulated during Differentiation of 3T3-L1 Cells and Contributes to the Highly Insulin-responsive Glucose Transport Activity. Journal of Biological Chemistry. 275(23). 17671–17676. 49 indexed citations
18.
Vanhaesebroeck, Bart, Gareth E. Jones, William E. Allen, et al.. (1999). Distinct PI(3)Ks mediate mitogenic signalling and cell migration in macrophages. Nature Cell Biology. 1(1). 69–71. 208 indexed citations
19.
Hooshmand-Rad, Roya, Lena Claesson‐Welsh, Stefan Wennström, et al.. (1997). Involvement of Phosphatidylinositide 3′-Kinase and Rac in Platelet-Derived Growth Factor-Induced Actin Reorganization and Chemotaxis. Experimental Cell Research. 234(2). 434–441. 104 indexed citations
20.
Rankin, Sara M., Roya Hooshmand-Rad, Lena Claesson‐Welsh, & Enrique Rozengurt. (1996). Requirement for Phosphatidylinositol 3′-Kinase Activity in Platelet-derived Growth Factor-stimulated Tyrosine Phosphorylation of p125 Focal Adhesion Kinase and Paxillin. Journal of Biological Chemistry. 271(13). 7829–7834. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cheng Fang Yu Breakdown of academic impact, for papers by V. Friand Breakdown of academic impact, for papers by Angela Orecchia Breakdown of academic impact, for papers by Nadezhda Tikhmyanova Breakdown of academic impact, for papers by Sandra van Wilpe Breakdown of academic impact, for papers by Simona Vertuani Breakdown of academic impact, for papers by Marie-Pierre Podgorniak Breakdown of academic impact, for papers by Honghong Sun Breakdown of academic impact, for papers by Sylvain M. Le Gall Breakdown of academic impact, for papers by Nuran Bektas
Rankless by CCL
2026